TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $7.65B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
Amgen USD 209.65B 14.21B Aug/2026
Ardelyx USD 1.48B 63M Mar/2026
Arrowhead Research USD 11.15B 2.37B Aug/2026
Bayer EUR 49.51B 10.82B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Curis USD 10M 2M Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 7.13B 1.28B Aug/2026
Verastem USD 147M 319M Aug/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026